Sotera Health (SHC)
(Delayed Data from NSDQ)
$15.97 USD
-0.28 (-1.72%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $15.98 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SHC 15.97 -0.28(-1.72%)
Will SHC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SHC
Should You Buy Sotera Health Company (SHC) After Golden Cross?
Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics
SHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Misses Revenue Estimates
Exploring Analyst Estimates for Sotera Health (SHC) Q2 Earnings, Beyond Revenue and EPS
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates
Other News for SHC
SHC forms Bollinger Band Squeeze on September 17
Sotera Health Amends Credit Agreement for $1.42 Billion
Sculptor Capital LP's Strategic Acquisition of Sotera Health Co Shares
Is SHC signaling a buying opportunity? 20 Day Moving Average Support shows up after climbing 0.43%
Is SHC poised for gains? Crossed Above 20 Day Moving Average shows up after climbing 1.12%